{"DataElement":{"publicId":"4101674","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm Confirmation Response Hematopoietic and Lymphoid Cell Neoplasm Response Type","preferredDefinition":"Information related to the confirmation or verification of pathologic and/or clinical changes that result from treatment for a cancer of the blood or bone marrow, such as leukemia or lymphoma._The type of response related to a cancer of the blood or bone marrow such as leukemia or lymphoma.","longName":"Hema_Conf_Resp_Hema_Resp_Type","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"4057015","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm Confirmation Response","preferredDefinition":"Information related to the confirmation or verification of pathologic and/or clinical changes that result from treatment for a cancer of the blood or bone marrow, such as leukemia or lymphoma.","longName":"Hema_Conf_Resp","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"4057012","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm","preferredDefinition":"A cancer of the blood or bone marrow, such as leukemia or lymphoma.","longName":"C27134","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic and Lymphoid Cell Neoplasm","conceptCode":"C27134","definition":"A neoplasm that arises from hematopoietic and lymphoid cells. Representative examples include myeloproliferative neoplasms, myelodysplastic syndromes, leukemias, Hodgkin lymphomas, and non-Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF7A7F80-F26C-BDD3-E040-BB89AD4354F1","latestVersionIndicator":"Yes","beginDate":"2014-01-08","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-08","modifiedBy":"ONEDATA","dateModified":"2014-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4057013","version":"1","preferredName":"Confirmation Response","preferredDefinition":"Having been established or verified.:The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression.","longName":"C25458:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF7A7F80-F27D-BDD3-E040-BB89AD4354F1","latestVersionIndicator":"Yes","beginDate":"2014-01-08","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-08","modifiedBy":"ONEDATA","dateModified":"2014-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF7A7F80-F28E-BDD3-E040-BB89AD4354F1","latestVersionIndicator":"Yes","beginDate":"2014-01-08","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-08","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4056992","version":"1","preferredName":"Hematopoietic and Lymphoid Cell Neoplasm Response Type","preferredDefinition":"The type of response related to a cancer of the blood or bone marrow such as leukemia or lymphoma.","longName":"Hema_Resp_Type","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Response criteria for Chronic Lymphocytic Leukemia","valueDescription":"Response criteria for Chronic Lymphocytic Leukemia","ValueMeaning":{"publicId":"4127726","version":"1","preferredName":"Response criteria for Chronic Lymphocytic Leukemia","longName":"4127726","preferredDefinition":"Response criteria for Chronic Lymphocytic Leukemia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F181E896-AC66-DDDB-E040-BB89AD4319A4","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F181E896-AC7F-DDDB-E040-BB89AD4319A4","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"ONEDATA","dateModified":"2014-02-03","deletedIndicator":"No"},{"value":"Response criteria for Lymphomas","valueDescription":"Response criteria for Lymphomas","ValueMeaning":{"publicId":"4127731","version":"1","preferredName":"Response criteria for Lymphomas","longName":"4127731","preferredDefinition":"Response criteria for Lymphomas","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F181E896-AC89-DDDB-E040-BB89AD4319A4","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F181E896-ACA2-DDDB-E040-BB89AD4319A4","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"ONEDATA","dateModified":"2014-02-03","deletedIndicator":"No"},{"value":"Response criteria for Acute Lymphocytic Leukemia","valueDescription":"Response criteria for Acute Lymphocytic Leukemia","ValueMeaning":{"publicId":"4127732","version":"1","preferredName":"Response criteria for Acute Lymphocytic Leukemia","longName":"4127732","preferredDefinition":"Response criteria for Acute Lymphocytic Leukemia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F181E896-ACAC-DDDB-E040-BB89AD4319A4","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F181E896-ACC5-DDDB-E040-BB89AD4319A4","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"ONEDATA","dateModified":"2014-02-03","deletedIndicator":"No"},{"value":"Response criteria for Acute Myeloid Leukemia","valueDescription":"Response criteria for Acute Myeloid Leukemia","ValueMeaning":{"publicId":"4127733","version":"1","preferredName":"Response criteria for Acute Myeloid Leukemia","longName":"4127733","preferredDefinition":"Response criteria for Acute Myeloid Leukemia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F181E896-ACCF-DDDB-E040-BB89AD4319A4","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F181E896-ACE8-DDDB-E040-BB89AD4319A4","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"ONEDATA","dateModified":"2014-02-03","deletedIndicator":"No"},{"value":"Response criteria for Multiple Myeloma","valueDescription":"Response criteria for Multiple Myeloma","ValueMeaning":{"publicId":"4127734","version":"1","preferredName":"Response criteria for Multiple Myeloma","longName":"4127734","preferredDefinition":"Response criteria for Multiple Myeloma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F181E896-ACF2-DDDB-E040-BB89AD4319A4","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F181E896-AD0B-DDDB-E040-BB89AD4319A4","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"ONEDATA","dateModified":"2014-02-03","deletedIndicator":"No"},{"value":"Response criteria for CML","valueDescription":"Response criteria for CML","ValueMeaning":{"publicId":"4127735","version":"1","preferredName":"Response criteria for CML","longName":"4127735","preferredDefinition":"Response criteria for CML","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F181E896-AD15-DDDB-E040-BB89AD4319A4","latestVersionIndicator":"Yes","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F181E896-AD2E-DDDB-E040-BB89AD4319A4","beginDate":"2014-02-03","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-02-03","modifiedBy":"ONEDATA","dateModified":"2014-02-03","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F01ED003-37BD-E216-E040-BB89AD4365D5","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"ONEDATA","dateModified":"2014-01-16","deletedIndicator":"No"},{"value":"Not a hematological malignancy","valueDescription":"Not a hematological malignancy","ValueMeaning":{"publicId":"4336884","version":"1","preferredName":"Not a hematological malignancy","longName":"4336884","preferredDefinition":"Not a hematological malignancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA78D2E8-011D-A49F-E040-BB89AD432947","latestVersionIndicator":"Yes","beginDate":"2014-05-28","endDate":null,"createdBy":"JONESN","dateCreated":"2014-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FA78D2E8-0136-A49F-E040-BB89AD432947","beginDate":"2014-05-28","endDate":null,"createdBy":"JONESN","dateCreated":"2014-05-28","modifiedBy":"ONEDATA","dateModified":"2014-05-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF7AC12D-A64D-AFF5-E040-BB89AD4373EA","latestVersionIndicator":"Yes","beginDate":"2014-01-08","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-08","modifiedBy":"CAMPBELB","dateModified":"2015-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"How was the response document","type":"Preferred Question Text","description":"How was the response documented for a hematological malignancy?","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F01DA4E9-D9FE-B0EF-E040-BB89AD436602","latestVersionIndicator":"Yes","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; Cleanup; 12/12/14 jc added Exceptional Responder CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}